These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9572887)

  • 21. Design and synthesis of 3,5-diarylisoxazole derivatives as novel class of anti-hyperglycemic and lipid lowering agents.
    Kumar A; Maurya RA; Sharma S; Ahmad P; Singh AB; Tamrakar AK; Srivastava AK
    Bioorg Med Chem; 2009 Jul; 17(14):5285-92. PubMed ID: 19500993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel euglycemic and hypolipidemic agents: Part-2. Antioxidant moiety as structural motif.
    Reddy KA; Lohray BB; Bhushan V; Reddy AS; Kishore PH; Rao VV; Saibaba V; Bajji AC; Rajesh BM; Reddy KV; Chakrabarti R; Rajagopalan R
    Bioorg Med Chem Lett; 1998 May; 8(9):999-1002. PubMed ID: 9871696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [[omega-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents.
    Cantello BC; Cawthorne MA; Cottam GP; Duff PT; Haigh D; Hindley RM; Lister CA; Smith SA; Thurlby PL
    J Med Chem; 1994 Nov; 37(23):3977-85. PubMed ID: 7966158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (2R)-2-ethylchromane-2-carboxylic acids: discovery of novel PPARalpha/gamma dual agonists as antihyperglycemic and hypolipidemic agents.
    Koyama H; Miller DJ; Boueres JK; Desai RC; Jones AB; Berger JP; MacNaul KL; Kelly LJ; Doebber TW; Wu MS; Zhou G; Wang PR; Ippolito MC; Chao YS; Agrawal AK; Franklin R; Heck JV; Wright SD; Moller DE; Sahoo SP
    J Med Chem; 2004 Jun; 47(12):3255-63. PubMed ID: 15163205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral bioavailability and pharmacokinetics of the new insulin sensitizer DRF-2189 in Wistar rats.
    Jajoo HK; Mamidi RN; Vakkalanka SV; Sathyavageeswaran S; Katneni K; Ayalasomayajula PS; Rao BP; Lohray BB; Subramaniam S
    Arzneimittelforschung; 1999 Feb; 49(2):133-6. PubMed ID: 10083982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel phthalazinone and benzoxazinone containing thiazolidinediones as antidiabetic and hypolipidemic agents.
    Madhavan GR; Chakrabarti R; Kumar SK; Misra P; Mamidi RN; Balraju V; Kasiram K; Babu RK; Suresh J; Lohray BB; Lohrayb VB; Iqbal J; Rajagopalan R
    Eur J Med Chem; 2001; 36(7-8):627-37. PubMed ID: 11600232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and biological evaluation of thiazole- and indole-based derivatives for the treatment of type II diabetes.
    Xu Q; Huang L; Liu J; Ma L; Chen T; Chen J; Peng F; Cao D; Yang Z; Qiu N; Qiu J; Wang G; Liang X; Peng A; Xiang M; Wei Y; Chen L
    Eur J Med Chem; 2012 Jun; 52():70-81. PubMed ID: 22483089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on antidiabetic agents. XII. Synthesis and activity of the metabolites of (+/-)-5(-)[p(-)[2-(5-ethyl-2-pyridyl)ethoxy]benzyl]-2,4- thiazolidinedione (pioglitazone).
    Sohda T; Ikeda H; Meguro K
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2168-72. PubMed ID: 8582019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Euglycaemic and biological activities of novel thiazolidine-2,4-dione derivatives.
    de Nanteuil G; Herve Y; Duhault J; Espinal J; Boulanger M; Ravel D
    Arzneimittelforschung; 1995 Nov; 45(11):1176-81. PubMed ID: 8929235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel spirosuccinimides with incorporated isoindolone and benzisothiazole 1,1-dioxide moieties as aldose reductase inhibitors and antihyperglycemic agents.
    Wrobel J; Dietrich A; Woolson SA; Millen J; McCaleb M; Harrison MC; Hohman TC; Sredy J; Sullivan D
    J Med Chem; 1992 Nov; 35(24):4613-27. PubMed ID: 1469692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihyperglycemic effects of newly synthesized 6,7-bis[2-(substitutedphenyl)-4-oxothiazolidin3yl1 quinoxaline 2,3-(1 FH, 4 H)-diones.
    Pawar PY; Bhise SB
    Indian J Physiol Pharmacol; 2006; 50(4):431-4. PubMed ID: 17402276
    [No Abstract]   [Full Text] [Related]  

  • 32. Design and synthesis of N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a novel peroxisome proliferator-activated receptor alpha/gamma dual agonist with efficacious glucose and lipid-lowering activities.
    Devasthale PV; Chen S; Jeon Y; Qu F; Shao C; Wang W; Zhang H; Cap M; Farrelly D; Golla R; Grover G; Harrity T; Ma Z; Moore L; Ren J; Seethala R; Cheng L; Sleph P; Sun W; Tieman A; Wetterau JR; Doweyko A; Chandrasena G; Chang SY; Humphreys WG; Sasseville VG; Biller SA; Ryono DE; Selan F; Hariharan N; Cheng PT
    J Med Chem; 2005 Mar; 48(6):2248-50. PubMed ID: 15771468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moiety.
    Collins JL; Blanchard SG; Boswell GE; Charifson PS; Cobb JE; Henke BR; Hull-Ryde EA; Kazmierski WM; Lake DH; Leesnitzer LM; Lehmann J; Lenhard JM; Orband-Miller LA; Gray-Nunez Y; Parks DJ; Plunkett KD; Tong WQ
    J Med Chem; 1998 Dec; 41(25):5037-54. PubMed ID: 9836621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on antidiabetic agents. 11. Novel thiazolidinedione derivatives as potent hypoglycemic and hypolipidemic agents.
    Sohda T; Mizuno K; Momose Y; Ikeda H; Fujita T; Meguro K
    J Med Chem; 1992 Jul; 35(14):2617-26. PubMed ID: 1635060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological activity of novel acridinylidene and benzylidene thiazolidinediones.
    Mourão RH; Silva TG; Soares AL; Vieira ES; Santos JN; Lima MC; Lima VL; Galdino SL; Barbe J; Pitta IR
    Eur J Med Chem; 2005 Nov; 40(11):1129-33. PubMed ID: 16040159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel tricyclic-alpha-alkyloxyphenylpropionic acids: dual PPARalpha/gamma agonists with hypolipidemic and antidiabetic activity.
    Sauerberg P; Pettersson I; Jeppesen L; Bury PS; Mogensen JP; Wassermann K; Brand CL; Sturis J; Wöldike HF; Fleckner J; Andersen AS; Mortensen SB; Svensson LA; Rasmussen HB; Lehmann SV; Polivka Z; Sindelar K; Panajotova V; Ynddal L; Wulff EM
    J Med Chem; 2002 Feb; 45(4):789-804. PubMed ID: 11831892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors.
    Onda K; Shiraki R; Ogiyama T; Yokoyama K; Momose K; Katayama N; Orita M; Yamaguchi T; Furutani M; Hamada N; Takeuchi M; Okada M; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2008 Dec; 16(23):10001-12. PubMed ID: 18952447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New potent antihyperglycemic agents in db/db mice: synthesis and structure-activity relationship studies of (4-substituted benzyl) (trifluoromethyl)pyrazoles and -pyrazolones.
    Kees KL; Fitzgerald JJ; Steiner KE; Mattes JF; Mihan B; Tosi T; Mondoro D; McCaleb ML
    J Med Chem; 1996 Sep; 39(20):3920-8. PubMed ID: 8831758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological activity of metabolites of the antidiabetic, antihyperglycemic agent pioglitazone.
    Tanis SP; Parker TT; Colca JR; Fisher RM; Kletzein RF
    J Med Chem; 1996 Dec; 39(26):5053-63. PubMed ID: 8978836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on antidiabetic agents. IV. Synthesis and activity of the metabolites of 5-[4-(1-methylcyclohexylmethoxy)benzyl]-2,4-thiazolidinedione (ciglitazone).
    Sohda T; Meguro K; Kawamatsu Y
    Chem Pharm Bull (Tokyo); 1984 Jun; 32(6):2267-78. PubMed ID: 6488400
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.